Silexion Therapeutics Corp Stock: price and insider trades · United States
Silexion Therapeutics Corp: what insiders have been doing
Silexion Therapeutics Corp belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). Between 22 October 2025 and 22 October 2026, 9 insiders published 16 filings.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €27k. Shirvan Mitchell filed the largest sale, €27k, on 30 March 2026.
Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 3,171 companies tracked on its exchange, the median is 24 filings; at 16 filings, this issuer sits below that mark. Over the whole record (from 2025), the tally stands at no purchases and 1 sale. The 10-K for the year ended 31 December 2025 shows -11.9 m USD of net income.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 22,818 shares@ US$1.36100.0% of flowOrdinary SharesSEC:0001178913-26-001858:0
- 9,091 shares0Ordinary SharesSEC:0001178913-26-000644:0
- 64,350 shares0Ordinary SharesSEC:0001178913-26-000600:0
- 9,091 shares0Ordinary SharesSEC:0001178913-26-000598:0
- 49,726 shares0Ordinary SharesSEC:0001178913-26-000604:0
- 49,726 shares0Ordinary SharesSEC:0001178913-26-000602:0
- 7,576 shares0Ordinary SharesSEC:0001178913-26-000596:0
- 9,091 shares0Ordinary SharesSEC:0001178913-26-000594:0
- 9,091 shares0Ordinary SharesSEC:0001178913-26-000606:0
- 450,000 shares@ US$4.00Ordinary SharesSEC:0001178913-26-000228:1
- 5,550 shares0Ordinary SharesSEC:0001178913-26-000228:0
- 661 shares0Ordinary SharesSEC:0001178913-25-004143:0
- 794 shares0Ordinary SharesSEC:0001178913-25-004151:0
- 794 shares0Ordinary SharesSEC:0001178913-25-004149:0
- 1,587 shares0Ordinary SharesSEC:0001178913-25-004147:0
- 1,587 shares0Ordinary SharesSEC:0001178913-25-004145:0
16 of 16 declarations
About Silexion Therapeutics Corp
Silexion Therapeutics Corp is a company focused on developing innovative therapies for the treatment of diseases. It is listed on the XNAS market.
